Apoptosis induction by p38 MAPK inhibitor in human colon cancer cells

Hepato-Gastroenterology

Volumn 55, Issue 84, 2008, Pages 930-935

  Tsuchiya, Takeshi ^a,b   Tsuno, Nelson H ^a   Asakage, Masahiro ^a   Yamada, Jun ^a   Yoneyama, Satomi ^a   Okaji, Yurai ^a   Sasaki, Shin ^a   Kitayama, Joji ^a   Osada, Takuya ^a   Takahashi, Koki ^a   Nagawa, Hirokazu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NONE   (Japan)

Author keywords

Colon cancer; FR167653; p38 MAPK

Indexed keywords

1 [7 (4 FLUOROPHENYL) 1,2,3,4 TETRAHYDRO 8 (4 PYRIDYL)PYRAZOLO[5,1 C][1,2,4]TRIAZIN 2 YL] 2 PHENYLETHANEDIONE; CASPASE 3; CASPASE 8; CASPASE 9; GELATINASE A; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR;

APOPTOSIS; ARTICLE; CANCER CELL; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASES; CELL ADHESION; CELL DIVISION; CELL MOVEMENT; COLONIC NEOPLASMS; HUMANS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRAZOLES; PYRIDINES; TUMOR CELLS, CULTURED;

EID: 47149085885     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Wada T, Penninger JM: Mitogen-activated protein kinases in apoptosis regulation. Oncogene 2004; 23:2838-2849.
2. Engelberg D: Stress-activated protein kinases-tumor suppressors or tumor initiators? Semin Cancer Biol 2004; 14:271-282.
3. Zhang J, Gao JX, Salojin K, Shao Q, Grattan M, Meagher C, Laird DW, Delovitch TL: Regulation of fas hgand expression during activation-induced cell death in T cells by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase. J Exp Med 2000; 191:1017-1030.
4. Le-Niculescu H, Bonfoco E, Kasuya Y, Claret FX, Green DR, Karin M: Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death. Mol Cell Biol 1999; 19:751-763.
5. Park JM, Greten FR, Li ZW, Karin M: Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science 2002; 297:2048-2051.
6. Roulston A, Reinhard C, Amiri P, Williams LT: Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor alpha. J Biol Chem 1998; 273:10232-10239.
7. Park JI, Lee MG, Cho K, Park BJ, Chae KS, Byun DS, Ryu BK, Park YK, Chi SG: Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways. Oncogene 2003; 22:4314-4332.
8. Kim MS, Lee EJ, Kim HR, Moon A: p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. Cancer Res 2003; 63:5454-5461.
9. Lee JC, Kassis S, Kumar S, Badger A, Adams JL: p38 mitogen-activated protein kinase inhibitors - mechanisms and therapeutic potentials. Pharmacol Ther 1999; 82:389-397.
10. Shimada K, Nakamura M, Ishida E, Konishi N: Molecular roles of MAP kinases and FADD phosphorylation in prostate cancer. Histol Histopathol 2006; 21:415-422.
11. Pomerance M, Quillard J, Chantoux F, Young J, Blondeau JP: High-level expression, activation, and subcellular localization of p38-MAP kinase in thyroid neoplasms. J Pathol 2006; 209:298-306.
12. Ringshausen I, Dechow T, Schneller F, Weick K, Oelsner M, Peschel C, Decker T: Constitutive activation of the MAPkinase p38 is critical for MMP-9 production and survival of B-CLL cells on bone marrow stromal cells. Leukemia 2004; 18:1964-1970.
13. Esteva FJ, Sahin AA, Smith TL, Yang Y, Pusztai L, Nahta R, Buchholz TA, Buzdar AU, Hortobagyi GN, Bacus SS: Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma. Cancer 2004; 100:499-506.
14. Zhang ZF, Ma JQ, Zhang L: Expression and clinical significance of MAPK in non-small cell lung cancer. Zhonghua Yi Xue Za Zhi 2005; 85:339-342.
15. Sun Y, Sinicrope FA: Selective inhibitors of MEK1/ERK44/42 and p38 mitogen-activated protein kinases potentiate apoptosis induction by sulindac sulfide in human colon carcinoma cells. Mol Cancer Ther 2005; 4:51-59.
16. Tominaga K, Higuchi K, Sasaki E, Suto R, Watanabe T, Fujiwara Y, Oshitani N, Matsumoto T, Kim S, Iwao H, Arakawa T: Correlation of MAP kinases with COX-2 induction differs between MKN45 and HT29 cells. Aliment Pharmacol Ther 2004; 20:143-150.
17. Aizawa S, Ookawa K, Kudo T, Asano J, Hayakari M, Tsuchida S: Characterization of cell death induced by ethacrynic acid in a human colon cancer cell line DLD-1 and suppression by N-acetyl-L-cysteine. Cancer Sci 2003; 94:886-893.
18. Juretic N, Santibanez JF, Hurtado C, Martinez J: ERK 1,2 and p38 pathways are involved in the proliferative stimuli mediated by urokinase in osteoblastic SaOS-2 cell line. J Cell Biochem 2001; 83:92-98.
19. Alvarado-Kristensson M, Melander F, Leandersson K, Ronnstrand L, Wernstedt C, Andersson T: p38-MAPK signals survival by phosphorylation of caspase-8 and caspase-3 in human neutrophils. J Exp Med 2004; 199:449-458.
20. Huang C, Jacobson K, Schaller MD: MAP kinases and cell migration. J Cell Sci 2004; 117:4619-4628.